Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/2/12 → 8/2/15 |
Funding
- PSI CRO AG (Study no. PH3-01)
- Galena Biopharma, Inc. (Study no. PH3-01)
Study no. PH3-01: PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax™ Treatment
- Santa-Maria, Cesar Augusto (PD/PI)
Project: Research project